Genetic Disorders and Hormonal Regulation in Parathyroid Dysfunction

Genetic disorders of the parathyroid gland predominantly arise from mutations or epigenetic alterations at the GNAS locus, which encodes the stimulatory G protein α-subunit (Gsα) and related transcripts. Aberrant imprinting and methylation patterns at differentially methylated regions (DMRs) within this locus disrupt normal parathyroid hormone (PTH) signalling, leading to conditions collectively termed pseudohypoparathyroidism (PHP) or, more broadly, inactivating PTH/PTH-related peptide signalling disorders (iPPSDs). These disorders manifest with PTH resistance, hypocalcaemia, hyperphosphataemia and, in certain subtypes, features of Albright hereditary osteodystrophy such as brachydactyly, subcutaneous ossifications and obesity. The interplay between genetic lesions—ranging from point mutations and small deletions to large duplications—and epigenetic mechanisms governs both the severity of hormone resistance and extra-skeletal phenotypes. Recent advances in mechanistic categorisation have clarified genotype–epigenotype correlations, enabling more precise molecular diagnoses. Complementary research on hormonal regulation has elucidated how impaired Gsα-mediated cyclic AMP generation underlies end-organ resistance, while investigations into alternative transcripts such as XLαs have highlighted their role in energy homeostasis and skeletal growth. Practical applications include methylation-sensitive diagnostic assays, novel classification frameworks for early identification, and targeted therapies such as recombinant growth hormone to ameliorate short stature. Continued integration of genetic, epigenetic and endocrine insights offers a route to personalised patient management and improved long-term outcomes.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Genetic Disorders and Hormonal Regulation in Parathyroid Dysfunction publication trend

The graph below shows the total number of articles in genetic disorders and hormonal regulation in parathyroid dysfunction across all publications each year (not limited to Nature Index journals).

Technical terms

Pseudohypoparathyroidism (PHP): A group of disorders characterised by resistance to parathyroid hormone leading to hypocalcaemia and hyperphosphataemia despite elevated PTH levels.

GNAS locus: A complex imprinted genomic region encoding multiple transcripts, including Gsα and XLαs, whose parent-of-origin expression governs hormone responsiveness.

Imprinting: An epigenetic process by which genes are expressed in a parent-specific manner, often mediated by DNA methylation at imprinting control regions.

Differentially Methylated Region (DMR): A genomic segment showing parent-specific methylation patterns that regulate allele-specific gene expression.

Gsα (Stimulatory G protein α-subunit): A GTP-binding protein that activates adenylate cyclase to generate cyclic AMP in response to hormone binding.

Haploinsufficiency: A state in which loss of function of one allele of a gene leads to insufficient protein production and a disease phenotype.

References

1. GNAS AS2 methylation status enables mechanism-based categorization of Pseudohypoparathyroidism Type 1B. JCI Insight (2024).
2. Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations. European Journal of Endocrinology (2023).
3. Genotype–Phenotype Correlation of GNAS Gene: Review and Disease Management of a Hotspot Mutation. International Journal of Molecular Sciences (2024).
4. From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. European Journal of Endocrinology (2016).
5. Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early‐Onset Obesity. Journal of Bone and Mineral Research (2018).
6. The Alternative Stimulatory G Protein α-Subunit XLαs Is a Critical Regulator of Energy and Glucose Metabolism and Sympathetic Nerve Activity in Adult Mice*. Journal of Biological Chemistry (2006).
7. Pseudohypoparathyroidism Type Ib Associated with Novel Duplications in the GNAS Locus. PLOS ONE (2015).